Edition:
United Kingdom

Heska Corp (HSKA.OQ)

HSKA.OQ on NASDAQ Stock Exchange Capital Market

100.28USD
19 Oct 2018
Change (% chg)

$0.19 (+0.19%)
Prev Close
$100.09
Open
$100.30
Day's High
$103.32
Day's Low
$98.62
Volume
11,396
Avg. Vol
16,285
52-wk High
$114.50
52-wk Low
$56.76

Chart for

About

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging... (more)

Overall

Beta: 0.82
Market Cap(Mil.): $694.57
Shares Outstanding(Mil.): 7.23
Dividend: --
Yield (%): --

Financials

  HSKA.OQ Industry Sector
P/E (TTM): 49.29 32.10 33.65
EPS (TTM): 1.95 -- --
ROI: 15.81 13.82 14.28
ROE: 17.12 16.56 16.00

BRIEF-Heska Reports Q1 Earnings Per Share Of $0.28

* Q1 EARNINGS PER SHARE VIEW $0.35 -- THOMSON REUTERS I/B/E/S

04 May 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $44.50 +0.50
Novartis AG (NOVN.S) CHF87.04 +1.16
Merck & Co., Inc. (MRK.N) $72.35 +0.14
Bayer AG (BAYGn.DE) €77.59 -0.83
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €77.80 0.00
Eli Lilly And Co (LLY.N) $111.92 -1.39
IDEXX Laboratories, Inc. (IDXX.OQ) $218.40 -5.93
Virbac SA (VIRB.PA) €147.00 +0.40
Vetoquinol SA (VETO.PA) €51.20 0.00

Earnings vs. Estimates